Page last updated: 2024-08-21

c.i. 42510 and Pharyngeal Neoplasms

c.i. 42510 has been researched along with Pharyngeal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bairati, I; Fortin, A; Monteil, RA; Morency, R; Raybaud, H; Têtu, B	1

Other Studies

1 other study(ies) available for c.i. 42510 and Pharyngeal Neoplasms

Article	Year
Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma. International journal of oral and maxillofacial surgery, 2000, Volume: 29, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Brachytherapy; Carcinoma, Squamous Cell; Cell Division; Coloring Agents; Diploidy; DNA, Neoplasm; Female; Follow-Up Studies; Forecasting; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Pharyngeal Neoplasms; Ploidies; Prognosis; Radiation Tolerance; Radiotherapy Dosage; Rosaniline Dyes; Tumor Suppressor Protein p53	2000

Article

Year

Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.

International journal of oral and maxillofacial surgery, 2000, Volume: 29, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Brachytherapy; Carcinoma, Squamous Cell; Cell Division; Coloring Agents; Diploidy; DNA, Neoplasm; Female; Follow-Up Studies; Forecasting; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Pharyngeal Neoplasms; Ploidies; Prognosis; Radiation Tolerance; Radiotherapy Dosage; Rosaniline Dyes; Tumor Suppressor Protein p53

2000